Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

Signing the MOUs on behalf of Dubai Investments, Mohammed Saeed Al Raqbani, General Manager, Dubai Investments Industries and ...

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

A new Marks and Spencer Foodhall could soon be built on a retail park on the outskirts of Boston, if plans are approved.

Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...